Introduction
Epistaxis is a common presentation to Ear, Nose and Throat (ENT) departments across the UK with the majority of requiring hospital admission despite most patients requiring no further intervention other than simple nasal packing1,2. Due to its involvement with the upper respiratory tract and being described as an aerosol generating procedure, the management of epistaxis posed an increased risk of the spread of Sars-CoV-2 to staff and patients3. In March 2020, new guidelines were altered to enable certain patients to be discharged home with nasal packs in situ to reduce the risk of COVID-19 inpatient transmission4. The literature has highlighted the implications around safe discharge, reduced hospital stay and re-admission rates for patients with epistaxis5,6.
A criterion was created to help identify patients that would be suitable for outpatient management. This included their social circumstances, stability of patients, observation parameters and past medical history. Correct adherence to the new guideline could lead to reduced admission of epistaxis patients and occupancy of beds within the hospital7.